Safety and potential efficacy of cyclooxygenase‐2 inhibitors in coronavirus disease 2019

OBJECTIVES: While the safety of non‐steroidal anti‐inflammatory drugs in COVID‐19 has been questioned, they may be beneficial given the hyper‐inflammatory immune response associated with severe disease. We aimed to assess the safety and potential efficacy of cyclooxygenase‐2 (COX‐2) selective inhibi...

Descripción completa

Detalles Bibliográficos
Autores principales: Ong, Sean Wei Xiang, Tan, Wilnard Yeong Tze, Chan, Yi‐Hao, Fong, Siew‐Wai, Renia, Laurent, Ng, Lisa FP, Leo, Yee‐Sin, Lye, David Chien, Young, Barnaby Edward
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7382954/
https://www.ncbi.nlm.nih.gov/pubmed/32728438
http://dx.doi.org/10.1002/cti2.1159

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7382954/
https://www.ncbi.nlm.nih.gov/pubmed/32728438
http://dx.doi.org/10.1002/cti2.1159

Ejemplares similares